Organ-specific overexpression of renal LAT2 and enhanced tubular L-DOPA uptake precede the onset of hypertension

Hypertension

Volumn 42, Issue 4 I, 2003, Pages 613-618

  Pinho, Maria João ^c   Gomes, Pedro ^c   Serrão, Maria Paula ^c   Bonifácio, Maria João ^a   Soares da Silva, Patrício ^b  

^a DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c NONE

Author keywords

Dopamine; Gene expression; Hypertension, renovascular; Kidney; Rats, spontaneously hypertensive

Indexed keywords

AMINO ACID TRANSPORTER; COMPLEMENTARY DNA; DOPAMINE; LEVODOPA; PHOSPHORUS 32;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; GENE EXPRESSION; GENE OVEREXPRESSION; HYPERTENSION; INTESTINE MUCOSA; KIDNEY CORTEX; KIDNEY EPITHELIUM; MALE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT STRAIN; REVERSE TRANSCRIPTION; SPONTANEOUSLY HYPERTENSIVE RAT;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANTIGENS, CD98 LIGHT CHAINS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; BIOLOGICAL TRANSPORT; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY; KIDNEY TUBULES, PROXIMAL; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; LEVODOPA; MALE; ORGAN SPECIFICITY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER;

EID: 0141962631     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000091822.00166.B1     Document Type: Article

References (44)

1. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol. 2000;62:621-647.
2. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens. 2002;11:87-92.
3. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol. 1987;252:F39-F45.
4. +-ATPase. Am J Physiol. 1990;258:F52-F60.
5. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol. 1990;259:F297-F303.
6. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension. 1998;32:187-197.
7. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther. 1998;80:149-182.
8. Jose PA, Eisner GM, Felder RA. Dopamine receptor-coupling defect in hypertension. Curr Hypertens Rep. 2002;4:237-244.
9. Herlitz H, Lundin S, Henning M, Aurell M, Karlberg BE, Berglund G. Hormonal pattern during development of hypertension in spontaneously hypertensive rats (SHR). Clin Exp Hypertens A. 1982;4:915-935.
10. Racz K, Kuchel O, Buu NT, Tenneson S. Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ Res. 1985;57: 889-897.
11. Kuchel O, Racz K, Debinski W, Falardeau P, Buu NT. Contrasting dopaminergic patterns in two forms of genetic hypertension. Clin Exp Hypertens A. 1987;9:987-1008.
12. Sanada H, Watanabe H, Shigetomi S, Fukuchi S. Gene expression of aromatic L-amino acid decarboxylase mRNA in the kidney of normotensive and hypertensive rats. Hypertens Res. 1995;18(suppl 1):S179-S181.
13. Yoshimura M, Ikegaki I, Nishimura M, Takahashi H. Role of dopaminergic mechanisms in the kidney for the pathogenesis of hypertension. J Auton Pharmacol. 1990;10:s67-s72.
14. Vieira-Coelho MA, Hussain T, Kansra V, Serrao MP, Guimaraes JT, Pestana M, Soares-da-Silva P, Lokhandwala MF. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension. 1999; 34:666-672.
15. Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol. 1990;258: F28-F33.
16. Soares-da-Silva P, Fernandes MH. Regulation of dopamine synthesis in the rat kidney. J Auton Pharmacol. 1990;10:s25-s30.
17. 0. +, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. J Membr Biol. 2002;186:63-80.
18. Soares-da-Silva P. Source and handling of renal dopamine: its physiological importance. News Physiol Sci. 1994;9:128-134.
19. Soares-da-Silva P, Fernandes MH, Pinto-do-Ó PC. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol. 1994;112:611-615.
20. Soares-da-Silva P, Pinto-do-Ó PC. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation. Br J Pharmacol. 1996;117: 1187-1192.
21. Pinto-do-Ó PC, Soares-da-Silva P. Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br J Pharmacol. 1996; 118:741-747.
22. Soares-da-Silva P. Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem Pharmacol. 1993;45:1791-1800.
23. 1 cells. Am J Physiol. 1998;274:F243-F251.
24. Adams JW, Migita DS, Yu MK, Young R, Hellickson MS, Castro-Vargas FE, Domingo JD, Lee PH, Bui JS, Henderson SA. Prostaglandin Fα stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem. 1996;271:1179-1186.
25. Motulsky HJ. Analyzing Data With GraphPad Prism, version 3.0 ed. San Diego, Calif: GraphPad Prism Software, Inc; 1999.
26. Grossman E, Hoffman A, Tamrat M, Armando I, Keiser HR, Goldstein DS. Endogenous DOPA and dopamine responses to dietary salt loading in salt-sensitive rats. J Hypertens. 1991;9:259-263.
27. Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Br J Pharmacol. 1995; 114:1403-1413.
28. + RNA. Biochim Biophys Acta. 2000;1466:61-70.
29. Kageyama T, Nakamura M, Matsuo A, Yamasaki Y, Takakura Y, Hashida M, Kanai Y, Naito M, Tsuruo T, Minato N, Shimohama S. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res. 2000;879:115-121.
30. Prasad PD, Wang H, Huang W, Kekuda R, Rajan DP, Leibach FH, Ganapathy V. Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun. 1999;255:283-288.
31. Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, Kuhn LC. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem. 1999;274:34948-34954.
32. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem. 1999;274:19745-19751.
33. Wagner CA, Lang F, Broer S. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol. 2001;281: C1077-C1093.
34. + ATPase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin Exp Hypertens. 2000;22:455-469.
35. Gill JRJ, Gullner HG, Lake R, Lakatua D, Lan G. Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension. 1988;11:312-319.
36. Soares-da-Silva P, Pestana M, Ferreira A, Damasceno A, Polonia J, Cerqueira-Gomes M. Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure. Clin Exp Hypertens. 2000;22:251-268.
37. Lee MR. Dopamine and the kidney: ten years on. Clin Sci. 1993;84: 357-375.
38. Soares-da-Silva P, Pestana M, Fernandes MH. Involvement of tubular sodium in the formation of dopamine in the human renal cortex. J Am Soc Nephrol. 1993;3:1591-1599.
39. 1 cells. Am J Physiol Renal Physiol. 2000;279:F736-F746.
40. Gomes P, Soares-da-Silva P. L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4. Brain Res. 1999;829:143-150.
41. Sampaio-Maia B, Serrao MP, Soares-da-Silva P. Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells. Am J Physiol Cell Physiol. 2001;280:C333-C342.
42. Jose PA, Eisner GM, Felder RA. Renal dopamine and sodium homeostasis. Curr Hypertens Rep. 2000;2:174-183.
43. Gomes P, Xu J, Serrao P, Doria S, Jose PA, Soares-da-Silva P. Expression and function of sodium transporters in two opossum kidney cell clonal sublines. Am J Physiol Renal Physiol. 2002;283:F73-F85.
44. 1-like receptor function in two opossum kidney cell clonal sublines. Cell Physiol Biochem. 2002;12:259-268.